文献速递介入妇产影像外周血管MRDSA

新型球形可吸收栓塞颗粒与五种常用栓塞剂在子宫肌瘤栓塞术中的回顾性队列比较

A retrospective cohort study comparing a novel, spherical, resorbable particle against five established embolic agents for uterine fibroid embolisation.
PubMed 文献 · Clin Radiol · 2021-02-23

本回顾性队列研究纳入120例接受子宫肌瘤栓塞术的患者,每组20例,比较6种栓塞剂(含新型明胶基全可吸收球形颗粒)术后3个月MRI测量的优势肌瘤梗死百分比(DF%)和全部肌瘤梗死百分比(AF%)。新型颗粒与其他栓塞剂在DF%(χ2=3.92,p=0.56)和AF%(χ2=2.83,p=0.73)上无显著差异,完全DF%的RR=1.07(0.90-1.27)、完全AF%的RR=1.09(0.85-1.41)提示非劣效;新型颗粒的子宫动脉通畅率优于明胶浆(82.5% vs 27.5%,Bonferroni校正后p<0.001)。

要点

  • 术后3个月MRI显示新型可吸收颗粒与其他栓塞剂的肌瘤梗死率无显著差异。
  • 完全优势肌瘤梗死RR=1.07(0.90-1.27)、完全全部肌瘤梗死RR=1.09(0.85-1.41),提示非劣效。
  • 新型颗粒子宫动脉通畅率82.5%,高于明胶浆的27.5%(Bonferroni校正后p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the effectiveness of a novel, resorbable, spherical embolic agent compared with other established agents, by studying percentage fibroid infarction (the best indicator of long-term symptom improvement) in patients undergoing uterine fibroid embolisation (UFE).

MATERIALS AND METHODS: This retrospective cohort study examined six different embolic agents used for fibroid embolisation, including a new gelatin-based, fully resorbable, spherical agent. The primary effectiveness outcomes were magnetic resonance imaging (MRI)-determined dominant fibroid infarct percentage (DF%) and all fibroid percentage infarct (AF%) at 3 months post-embolisation. MRI-determined uterine artery patency rate was the secondary outcome. Chi-squared test (χ2), relative risk (RR) calculation (primary outcomes), and analysis of variance (ANOVA) (secondary outcome) were the statistical tests employed.

RESULTS: One hundred and twenty patients were treated with six embolic agents (20 consecutive patients per group, overall mean age 44.8±6.4, initial uterine volume 570±472 ml, dominant fibroid volume 249±324 ml). Fibroid infarctrates were similar between the cohorts with no significant difference between the new gelatin-based resorbable particle and other embolics in either DF% (χ2=3.92, p=0.56) or AF% (χ2=2.83, p=0.73). Complete DF% RR=1.07 (0.90-1.27) and AF% RR=1.09 (0.85-1.41) suggest non-inferiority of the resorbable particle (d=0.67, p<0.05). A favourable uterine artery patency rate was demonstrated for the resorbable particle compared with gelatin slurry (82.5% versus 27.5%, p<0.001 after Bonferroni adjustment).

CONCLUSIONS: This new gelatin-based, fully resorbable particle is an effective embolic agent for fibroid embolisation and achieves an infarct rate non-inferior to established embolics.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Maclean D, Vigneswaran G, Bryant T, et al. A retrospective cohort study comparing a novel, spherical, resorbable particle against five established embolic agents for uterine fibroid embolisation. Clin Radiol. 2021. PMID: 33637311. doi:10.1016/j.crad.2021.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。